Strides Pharma Archives - Express Pharma

Strides strengthens its Africa business with acquisition of multiple generic brands from Sandoz

Strides Pharma to market WHO-prequalified generic DMPA-SC in Africa

Sustainable packaging solutions in pharma industry

Strides Pharma receives USFDA approval for Celecoxib Capsules in multiple strengths

Strides Pharma recognised in S&P Global Sustainability Yearbook 2025

Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

Strides Pharma secures shareholder and creditor approval for OneSource Pharma CDMO Initiative

Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg

Strides Alathur receives EIR from USFDA for its Chennai facility

Glenmark, Strides Pharma and Cipla recall products in US